View : 728 Download: 0
Positive Fecal Immunochemical Test Results Are Associated with Increased Risks of Esophageal, Stomach, and Small Intestine Cancers
- Title
- Positive Fecal Immunochemical Test Results Are Associated with Increased Risks of Esophageal, Stomach, and Small Intestine Cancers
- Authors
- Jung, Yoon Suk; Lee, Jinhee; Moon, Chang Mo
- Ewha Authors
- 문창모
- SCOPUS Author ID
- 문창모
- Issue Date
- 2020
- Journal Title
- JOURNAL OF CLINICAL MEDICINE
- ISSN
- 2077-0383
- Citation
- JOURNAL OF CLINICAL MEDICINE vol. 9, no. 7
- Keywords
- fecal immunochemical test; esophageal cancer; gastric cancer; small intestine cancer
- Publisher
- MDPI
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Background:The current guideline does not recommend upper gastrointestinal evaluation for patients with a positive fecal immunochemical test (FIT) and negative colonoscopy results. However, this indication was based on low-quality evidence as data on this issue are very limited. We assessed the risk of proximal cancers (oral or throat, esophageal, stomach, and small intestine cancers) after negative or positive FIT results in the Korean National Cancer Screening Program (NCSP).Methods:Using the NCSP databases, we collected data on participants who underwent FIT between 2009 and 2011. Participants were classified based on FIT results and colorectal cancer (CRC) diagnosed within 1 year after FIT as FIT- (n= 5,551,755), FIT+/CRC- (n= 368,553), and FIT+/CRC+ (n= 12,236).Results:The incidence rates of overall proximal cancers in FIT-, FIT+/CRC-, and FIT+/CRC+ patients within 1, 2, and 3 years after FIT were 0.38%, 0.68%, and 2.26%; 0.57%, 0.93%, and 2.74%; and 0.79%, 1.21%, and 3.15%, respectively. After adjusting confounding variables, the risks of esophageal, stomach, and small intestine cancers as well as overall proximal cancers within 1, 2, and 3 years after FIT were higher in FIT+/CRC- patients than those in FIT- patients. However, the risk of oral or throat cancer did not differ between FIT- and FIT+/CRC- patients. The risks for oral or throat cancer and small intestine cancer were higher in FIT+/CRC+ patients than those in FIT+/CRC- patients.Conclusions:In this population-based study, FIT+/CRC- patients were at higher risk for esophageal, stomach, and small intestine cancers than were FIT- patients, suggesting that positive FIT results were associated with these cancers.
- DOI
- 10.3390/jcm9072172
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML